These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 572278)

  • 1. Pharmacokinetic and pharmacodynamic effects of small doses of norethisterone released from vaginal rings continuously during 90 days.
    Landgren BM; Johannisson E; Masironi B; Diczfalusy E
    Contraception; 1979 Mar; 19(3):253-71. PubMed ID: 572278
    [No Abstract]   [Full Text] [Related]  

  • 2. A pharmacokinetic and pharmacodynamic study of a 'visiting pill' containing norethisterone.
    Song S; Chen JK; Yang PJ; Cheng DH; Liu WY; Fotherby K
    Contraception; 1986 Sep; 34(3):269-82. PubMed ID: 3539510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of three injections of norethisterone oenanthate on ovarian function.
    Dhall K; Dash RJ; Chadha U; Rastogi GK; Devi PK
    Indian J Med Res; 1979 Jan; 69():93-8. PubMed ID: 429052
    [No Abstract]   [Full Text] [Related]  

  • 4. Ultrastructure of human uterine epithelium at the time of implantation after postovulatory administration of norethindrone.
    Nilsson O; Nygren KG
    Ups J Med Sci; 1974; 79(2):65-71. PubMed ID: 4837833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormonal effects of the 300 microgram norethisterone (NET) minipill. I. Daily steroid levels in 43 subjects during a pretreatment cycle and during the second month of NET administration.
    Landgren BM; Diczfalusy E
    Contraception; 1980 Jan; 21(1):87-113. PubMed ID: 7357872
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma levels of norethindrone after i.m. injection of 200 mg norethindrone enanthate.
    Weiner E; Johansson ED
    Contraception; 1975 Apr; 11(4):419-25. PubMed ID: 1122756
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum progesterone and norethisterone levels following injection of norethisterone enanthate in different sites and doses.
    Joshi JV; Hazari KT; Shah RS; Chadha UC; Chitlange S; Gokral JS; Arolkar SG
    Steroids; 1989 Jun; 53(6):751-61. PubMed ID: 2815152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum norethindrone (NET) concentrations following intramuscular NET enanthate injection. Effect upon serum LH, FSH, estradiol and progesterone.
    Goebelsmann U; Stanczyk FZ; Brenner PF; Goebelsmann AE; Gentzschein EK; Mishell DR
    Contraception; 1979 Mar; 19(3):283-313. PubMed ID: 572279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of norethindrone acetate released from a single silastic implant on serum FSH, LH, progesterone and estradiol-17beta of women during first eight months of treatment.
    Rahman SA; Jha P; Laumas V; Jain AK; Dileepkumar ; Takkar D; Hingorani V; Laumas KR
    Contraception; 1977 Nov; 16(5):487-97. PubMed ID: 590011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma levels of norethisterone in women receiving norethisterone oenanthate intramuscularly.
    Howard G; Warren RJ; Fotherby K
    Contraception; 1975 Jul; 12(1):45-52. PubMed ID: 1139949
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma levels of norethindrone and effect upon ovarian function during treatment with silastic implants containing norethindrone.
    Odlind V; Weiner E; Johansson ED
    Contraception; 1979 Feb; 19(2):197-206. PubMed ID: 428235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence of ovulation in women receiving the injectable contraceptive norethisterone oenanthate.
    Fotherby K; Howard G; Shrimanker K; Elder M; Bye PG
    Contraception; 1978 Nov; 18(5):535-42. PubMed ID: 729379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The optimal dose of oral norethindrone acetate for addition to transdermal estradiol: a multicenter study.
    Fraser DI; Parsons A; Whitehead MI; Wordsworth J; Stuart G; Pryse-Davies J
    Fertil Steril; 1990 Mar; 53(3):460-8. PubMed ID: 2407564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical studies on endometrium from postmenopausal women receiving hormone replacement therapy.
    King RJ; Whitehead MI; Campbell S; Minardi J
    Postgrad Med J; 1978; 54 Suppl 2():65-8. PubMed ID: 216982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of norethisterone on pressor response to angiotensin II in men.
    Mabe K; Ito M; Okamura H
    Obstet Gynecol; 1992 Aug; 80(2):291-5. PubMed ID: 1635747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fabrication and testing of vaginal contraceptive devices designed for release of prespecified dose levels of steroids.
    Burton FG; Skiens WE; Gordon NR; Veal JT; Kalkwarf DR; Duncan GW
    Contraception; 1978 Mar; 17(3):221-30. PubMed ID: 648146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of norethisterone on pituitary and ovarian function.
    Collins WP; Koullapis EN; Ferguson KM; Biswas S; Sharples MJ; Sommerville IF
    Acta Endocrinol (Copenh); 1974 Feb; 75(2):357-67. PubMed ID: 4406549
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of intra-uterine and oral contraceptives on the ultrastructure of the human endometrium.
    Wynn RM; Sawaragi I
    J Reprod Fertil Suppl; 1969 Jun; 8():Suppl 8:45+. PubMed ID: 4318720
    [No Abstract]   [Full Text] [Related]  

  • 19. Subdermal norethindrone pellets -- a method for contraception?
    Odlind V; Moo-Young AJ; Gupta GN; Weiner E; Johansson ED
    Contraception; 1979 Jun; 19(6):639-48. PubMed ID: 487813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of norethisterone oenanthate on ovarian function.
    Weiner E; Johansson ED
    Acta Endocrinol (Copenh); 1976 Oct; 83(2):386-92. PubMed ID: 989667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.